Becton, Dickinson and Company

Equities

BDX

US0758871091

Medical Equipment, Supplies & Distribution

Market Closed - Nyse 04:00:02 2024-06-03 pm EDT 5-day change 1st Jan Change
238.8 USD +2.96% Intraday chart for Becton, Dickinson and Company +4.39% -2.05%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Sector Update: Health Care Stocks Steady Premarket Monday MT
Becton Dickinson to Acquire Edwards Lifesciences' Critical Care Product Group for $4.2 Billion in Cash DJ
Becton, Dickinson to Acquire Edwards Lifesciences' Critical Care Product Division for $4.2 Billion in Cash MT
Edwards Lifesciences to sell critical care products unit to Becton Dickinson for $4.2 bln RE
Becton, Dickinson to Acquire Edwards Lifesciences' Critical Care Product Group for $4.2 Billion MT
Becton, Dickinson and Company entered into an agreement to acquire Critical Care Product Group of Edwards Lifesciences Corporation (NYSE : EW) for $4.2 billion. CI
DBS Bank Adjusts Price Target on Becton, Dickinson to $285 From $300 MT
Transcript : Becton, Dickinson and Company Presents at Bank of America Health Care Conference 2024, May-14-2024 08:00 AM
Exclusive-Biden to put tariffs on China medical supplies - sources RE
Barclays Adjusts Price Target on Becton, Dickinson to $312 From $305, Keeps Overweight Rating MT
TD Cowen Adjusts Price Target on Becton, Dickinson and Company to $260 From $271 MT
Evercore ISI Raises Becton, Dickinson and Company Price Target to $282 From $280 MT
Sector Update: Health Care Stocks Mixed Premarket Thursday MT
Sector Update: Health Care MT
Transcript : Becton, Dickinson and Company, Q2 2024 Earnings Call, May 02, 2024
Becton, Dickinson's Fiscal Q2 Adjusted Earnings, Revenue Rise; Fiscal 2024 Outlook Revised MT
Becton Dickinson Shakes Up 2024 Outlook After Growing 2Q Sales, Earnings DJ
(BDX) BD (BECTON DICKINSON AND COMPANY) Expects Fiscal Year 2024 EPS Range $12.95 - $13.15 MT
Earnings Flash (BDX) BD (BECTON DICKINSON AND COMPANY) Reports Q2 Revenue $5.05B, vs. Street Est of $5.04B MT
Earnings Flash (BDX) BD (BECTON DICKINSON AND COMPANY) Posts Q2 EPS $3.17, vs. Street Est of $2.97 MT
Becton, Dickinson and Company Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2024 CI
Becton, Dickinson and Company Revises Earnings Guidance for the Fiscal Year 2024 CI
BD Maintains Quarterly Dividend at $0.95 Per Share; Payable June 28 to Shareholders of Record on June 10 MT
Becton, Dickinson and Company Declares Quarterly Dividend, Payable on June 28, 2024 CI
Becton, Dickinson and Company acquired FlowJo LLC. CI
Chart Becton, Dickinson and Company
More charts
Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical equipment (73.5%): surgical instruments, urological care products, pharmaceutical systems, etc.; - diagnostic materials (18.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, etc.; - clinical research and development tools (7.8%): tools for discovering drugs and vaccines, studying genes, culturing cells, and manipulating liquids, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (57.4%), Europe/Middle East/Africa (21.9%), Asia (15%) and other (5.7%).
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
A
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
17
Last Close Price
238.8 USD
Average target price
278.7 USD
Spread / Average Target
+16.68%
Consensus